Medicines the European Medicines Agency has recommended for use in the European Union on this topic.
Each number has its full source under its own list below.
16 medicines (authorised now). Newest first. Each links to its EMA page.
Active substance: trenibotulinumtoxinE
Active substance: naloxone hydrochloride dihydrate
Active substance: pregabalin
Active substance: duloxetine
Active substance: pregabalin
Active substance: pregabalin
Active substance: duloxetine
Active substance: pregabalin
Active substance: duloxetine
Active substance: pregabalin
Active substance: regadenoson
Active substance: perflutren
Active substance: duloxetine
Active substance: duloxetine hydrochloride
Active substance: pregabalin
Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.
Countries side by side on public measures for this topic.
Worldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report Digital HealthWorldwide · 2024–2034
View report Digital HealthWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
About 322 million people live with depression. Treatment works, but most people still do not get it.
ReadAcuitas market sizes and forecasts are only in our full reports. How we use public data.